The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: panitumumab     Injury: Palmar-plantar erythrodysaesthesia syndrome     Quarter: 2016Q3

Total Records: 7     Number of Pages: 1

Event ID DRUGNAME PT Drug Manufacturer Patient Age Sex Weight Date (YYYYMMDD) Country
88186503 PANITUMUMAB Palmar-plantar erythrodysaesthesia syndrome ROCHE 0.00 0 20160913 DK
118002247 panitumumab Palmar-plantar erythrodysaesthesia syndrome AMGEN 79.00 YR F 32 KG 20160910 JP
122329126 panitumumab Palmar-plantar erythrodysaesthesia syndrome AMGEN 59.00 YR M 66 KG 20160811 JP
124317734 panitumumab Palmar-plantar erythrodysaesthesia syndrome AMGEN 67.00 YR F 55 KG 20160803 JP
124904633 panitumumab Palmar-plantar erythrodysaesthesia syndrome AMGEN 0.00 F 55 KG 20160711 JP
126918812 panitumumab Palmar-plantar erythrodysaesthesia syndrome AMGEN 65.00 YR M 69 KG 20160906 JP
127567761 panitumumab Palmar-plantar erythrodysaesthesia syndrome AMGEN 66.00 YR M 61 KG 20160917 JP

Total Records: 7     Number of Pages: 1